Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker TJX
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | Jackwyn Nemerov Director | TJX TJX Companies, Inc. | Sale | 957 | $168.60 | $161.4K Sale | Form 4 ↗ |
| Jun 10, 2026 | Peter Benjamin SEVP, Group President | TJX TJX Companies, Inc. | Sale | 10,926 | $165.00 | $1.8M Sale | Form 4 ↗ |
| Jun 9, 2026 | Carol Meyrowitz Executive Chairman, Director | TJX TJX Companies, Inc. | Sale | 55,624 | $163.65 | $9.1M Sale | Form 4 ↗ |
| Jun 5, 2026 | John Klinger SEVP, CFO | TJX TJX Companies, Inc. | Sale | 6,235 | $160.77 | $1.0M Sale | Form 4 ↗ |
| Jun 5, 2026 | Ernie Herrman CEO & President, Director | TJX TJX Companies, Inc. | Sale | 10,002 | $160.68 | $1.6M Sale | Form 4 ↗ |
| Jun 4, 2026 | Ernie Herrman CEO & President, Director | TJX TJX Companies, Inc. | Sale | 28,000 | $158.33 | $4.4M Sale | Form 4 ↗ |
| Jun 3, 2026 | Kenneth Canestrari SEVP - Group President | TJX TJX Companies, Inc. | Sale | 31,447 | $157.50 | $5.0M Sale | Form 4 ↗ |
| Jun 3, 2026 | Ernie Herrman CEO & President, Director | TJX TJX Companies, Inc. | Sale | 29,549 | $157.46 | $4.7M Sale | Form 4 ↗ |
| Mar 2, 2026 | Ernie Herrman CEO & President, Director | TJX TJX Companies, Inc. | Sale | 30,000 | $160.95 | $4.8M Sale | Form 4 ↗ |
| Nov 21, 2025 | Ernie Herrman CEO & President, Director | TJX TJX Companies, Inc. | Sale | 24,363 | $151.31 | $3.7M Sale | Form 4 ↗ |
| Nov 21, 2025 | Amy B. Lane Director | TJX TJX Companies, Inc. | Sale | 500 | $151.40 | $75.7K Sale | Form 4 ↗ |
| Nov 20, 2025 | Ernie Herrman CEO & President, Director | TJX TJX Companies, Inc. | Sale | 30,000 | $148.81 | $4.5M Sale | Form 4 ↗ |
| Sep 8, 2025 | Peter Benjamin SEVP, Group President | TJX TJX Companies, Inc. | Sale | 1,500 | $139.23 | $208.8K Sale | Form 4 ↗ |
| Sep 2, 2025 | Jackwyn Nemerov Director | TJX TJX Companies, Inc. | Sale | 1,192 | $138.00 | $164.5K Sale | Form 4 ↗ |
| Jun 3, 2025 | Amy B. Lane Director | TJX TJX Companies, Inc. | Sale | 950 | $128.09 | $121.7K Sale | Form 4 ↗ |
| May 22, 2025 | Peter Benjamin SEVP, Group President | TJX TJX Companies, Inc. | Sale | 4,123 | $129.77 | $535.0K Sale | Form 4 ↗ |
| Mar 20, 2025 | Ernie Herrman CEO & President, Director | TJX TJX Companies, Inc. | Sale | 3,000 | $116.56 | $349.7K Sale | Form 4 ↗ |
| Mar 20, 2025 | Ernie Herrman CEO & President, Director | TJX TJX Companies, Inc. | Sale | 15,000 | $116.54 | $1.7M Sale | Form 4 ↗ |
| Mar 5, 2025 | Ernie Herrman CEO & President, Director | TJX TJX Companies, Inc. | Sale | 23,428 | $123.04 | $2.9M Sale | Form 4 ↗ |
| Feb 27, 2025 | Alan M. Bennett Director | TJX TJX Companies, Inc. | Sale | 8,000 | $123.53 | $988.2K Sale | Form 4 ↗ |
| Dec 5, 2024 | Ernie Herrman CEO & President, Director | TJX TJX Companies, Inc. | Sale | 7,533 | $126.18 | $950.5K Sale | Form 4 ↗ |
| Nov 27, 2024 | Amy B. Lane Director | TJX TJX Companies, Inc. | Sale | 1,000 | $126.93 | $126.9K Sale | Form 4 ↗ |
| Nov 22, 2024 | Ernie Herrman CEO & President, Director | TJX TJX Companies, Inc. | Sale | 19,149 | $121.27 | $2.3M Sale | Form 4 ↗ |
| Mar 3, 2022 | Amy B. Lane Director | TJX TJX Companies, Inc. | Buy | 2 | $66.13 | $118 Buy | Form 4 ↗ |
| Mar 3, 2022 | Amy B. Lane Director | TJX TJX Companies, Inc. | Buy | 22 | $66.13 | $1,478 Buy | Form 4 ↗ |
| Dec 2, 2021 | Amy B. Lane Director | TJX TJX Companies, Inc. | Buy | 2 | $71.26 | $119 Buy | Form 4 ↗ |
| Dec 2, 2021 | Amy B. Lane Director | TJX TJX Companies, Inc. | Buy | 21 | $71.26 | $1,473 Buy | Form 4 ↗ |
| Sep 2, 2021 | Amy B. Lane Director | TJX TJX Companies, Inc. | Buy | 2 | $72.54 | $115 Buy | Form 4 ↗ |
| Sep 2, 2021 | Amy B. Lane Director | TJX TJX Companies, Inc. | Buy | 20 | $72.54 | $1,467 Buy | Form 4 ↗ |
| Jun 3, 2021 | Amy B. Lane Director | TJX TJX Companies, Inc. | Buy | 2 | $66.99 | $115 Buy | Form 4 ↗ |
| Jun 3, 2021 | Amy B. Lane Director | TJX TJX Companies, Inc. | Buy | 22 | $66.99 | $1,462 Buy | Form 4 ↗ |
| Mar 4, 2021 | Amy B. Lane Director | TJX TJX Companies, Inc. | Buy | 2 | $64.87 | $112 Buy | Form 4 ↗ |
| Mar 4, 2021 | Amy B. Lane Director | TJX TJX Companies, Inc. | Buy | 22 | $64.87 | $1,456 Buy | Form 4 ↗ |
33 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:30 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances